However, MyD88 is a required adapter protein in most, but not all, LPS- and IL-1β-activated signaling pathways, making it the most reasonable first target for in vivo studies aimed at determining a potential role for TLR and/or IL1R1 activation in FOP. The gene discussed is MYD88; the disease is fibrodysplasia ossificans progressiva.